Avandia (rosignlatazone), a popular diabetes medication manufactured by GlaxoSmithKline, has been linked to tens of thousands of heart attacks (myocardial infarctions). A recent report released by the Senate Finance Committee in February 2010 found that Avandia’s manufacturer knew of possible heart attack risks years before such evidence became public. Instead of sufficiently warning patients and the FDA of its concerns in a timely manner, GlaxoSmithKline tried to downplay findings that Avandia could increase the risk of heart attacks. The senate committee report was critical of the FDA’s support of Avandia, asking the FDA why it allowed clinical trials of Avandia to continue even after the agency estimated that Avandia caused 83,000 heart attacks between 1999 and 2007. Included within the senate committee report were studies by two FDA doctors who said in 2008 the drug should be pulled from the market.
Related Topics
Avandia was linked to 304 deaths during the third quarter of 2009, ranking first among all prescribed drugs in the number of serious, disabling and fatal problems reported to the FDA. Hundreds of thousands of people still take Avandia, even though the American Diabetes Association recommended in 2008 that doctors use other drugs instead of Avandia in light of potential heart problems.
Under pressure from the senate finance committee, the FDA has scheduled a meeting of outside of advisors in July to discuss Avandia.
AVANDIA LAWSUITS
If you or a loved one have used Avandia and have suffered a heart attack, congestive heart failure, any heart complications or any other serious injury, you may be able to file an Avandia lawsuit against Avandia’s manufacturer. Contact one of our Avandia injury lawyers immediately for a free evaluation of your legal rights and options. Please call us now at 877-799-1414 or use this contact form to speak to an Avandia attorney to see if you qualify.
